BALTIMORE, May 29 /PRNewswire/ -- FASgen Diagnostics, LLC (Baltimore) and Tetracore, Inc. (Rockville) have announced that they have entered into a collaboration to produce cGMP ELISA and IHC tests for cancer biomarkers using FASgen's proprietary antibodies. The tests measure the over-expression of the enzyme fatty acid synthase (FAS), which is found in virtually all solid tumor cancers. FASgen's FAS-detect(TM) Elisa and FAS-detect(TM) IHC tests, currently available for research purposes, have demonstrated repeated and highly significant success in identifying the progression of the disease in a series of different solid tumors, including, pancreas, ovarian, prostate and lung cancer. These research results were recently the subject of multiple independent papers and presentations at the AACR annual meeting and at the earlier annual meeting of the Society of Gynecological Oncologists.
FASgen Diagnostics and Tetracore have been working together for the
last six years and the current transaction expands the antibody and kit
production role to Tetracore's FDA approved GMP production facility.
Tetracore has previously been the primary source of certain new proprietary
FASgen antibodies that form the core of the FAS-detect(TM) Elisa and
FAS-detect(TM) IHC tests. Tetracore has also been given the opportunity to
invest in FASgen Diagnostics. "We welcome the opportunity to expand our
working relationship with the FASgen Diagnostics team, and are very pleased
that they were willing to select Tetracore as the first outside corporate
investor to participate in their Company," said Dr. William Nelson,
President of Tetracore Inc. "These FAS diagnostic tests represent a new
bio-marker platform test for monitoring cancer and will be highly
complementary to existing tests to the benefit of patients and clinicians,"
said Dr. Frank Kuhajda, Professor of Biochemistry and Pathology at Johns
Hopkins Medical School and a Founder of FASgen Diagnostics, and who is also
|SOURCE FASgen Diagnostics, LLC|
Copyright©2008 PR Newswire.
All rights reserved